HyperBio Therapeutics ApS is a Danish APS based in Vejle Øst, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company has 1 employee and reported revenue of -74,5 t kr. in its latest annual filing.
-0,1 mio. kr.
−99% vs 2022
Solidity ratio Equity ÷ Total assets × 100 2020 2023
Liquidity ratio Current assets ÷ Short-term debt 2020 2023
Return on assets (ROA) Net profit ÷ Total assets × 100 2020 2023
EBITDA — year on year DKK millions 0M -4M -8M -12M -16M 2020: -6M -6M 2020 2021: -13M (-117% vs 2020) -13M -117% 2021 2022: -9M (+31% vs 2021) -9M +31% 2022 2023: 0M (+100% vs 2022) 0M 2023
Key figures Annual report 2023 Revenue -0,1 mio. kr. -99% EBITDA -0,1 mio. kr. +99% Net profit -1 mio. kr. +87% Total assets 14,7 mio. kr. -6% Equity 0,7 mio. kr. +132% Employees 1 —
Legal name
HyperBio Therapeutics ApS
Founded
12 March 2020 · 6 years
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in Vejle All Denmark companiesFinancial development In its most recent annual report (2023), HyperBio Therapeutics ApS reported a gross profit of -74,5 t kr.. The figures on this page draw on 4 annual filings covering 2020 to 2023. The bottom line showed a net loss of 972,7 t kr..
At the end of 2023, equity financed 5% of the balance sheet, and current assets covered short-term debt 1.1 times. HyperBio Therapeutics ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of HyperBio Therapeutics ApS? HyperBio Therapeutics ApS is registered with CVR / Virk under CVR 41244909.
What is the revenue of HyperBio Therapeutics ApS? HyperBio Therapeutics ApS reported revenue of -74,5 t kr. in 2023.
How many employees does HyperBio Therapeutics ApS have? HyperBio Therapeutics ApS employs 1 people as of the latest annual report.
Where is HyperBio Therapeutics ApS headquartered? HyperBio Therapeutics ApS's registered address is Stærmosevej 12.
More on HyperBio Therapeutics ApS